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A B S T R A C T
Background: Little data exist about the spatial distribution of the risk for travelers of being injured by a
potentially rabid animal.
Methods: Over the last 14 years, animal-associated injuries in 424 international travelers presenting to a
travel medicine clinic in Marseille, southern France, were investigated.
Results: The majority of cases were reported from North Africa (41.5%) and Asia (22.2%). Most countries
where at-risk injuries occurred (Algeria, Morocco, Tunisia, Thailand, and Turkey) were those for which
travelers do not usually seek advice at a specialized travel clinic, because these countries are not at risk
for speciﬁc travel-associated diseases like malaria or yellow fever. The probability of travelers being
attacked by each animal species varied signiﬁcantly according to the destination country. Dogs were
more frequently involved in Algeria, cats in Tunisia and the Middle East, and non-human primates in
sub-Saharan Africa, Madagascar, and Asia.
Conclusions: We suggest that rabies pre-exposure vaccination should be offered to individuals traveling
regularly to North Africa to visit their relatives and who are at high risk of exposure to potentially rabid
animal attacks. Pre-travel advice when addressing rabies prevention should consider the speciﬁc
epidemiology of animal-related injuries in the traveled country, as well as the traveler’s characteristics.
Travelers should be advised about which species of animal are potentially aggressive in their destination
country so that they can more easily avoid risk-contacts.
 2009 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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journa l homepage: www.e lsev ier .com/ locate / i j id1. Introduction
Some recent reports are available indicating the incidence of
potential rabies exposure in travelers, but are limited to a single
country or to speciﬁc populations of long-term expatriates.1–5
Little data exist about the spatial distribution of the risk of being
injured by a potentially rabid animal. An analysis of animal-
associated injuries in travelers in the GeoSentinel Surveillance
Network found that among 320 exposure incidents that occurred
in rabies endemic countries, 50% were in individuals traveling for
tourism for less than 3 weeks. The top countries for animal-related
injuries were: Thailand, India, Indonesia, China, Nepal, and
Vietnam.6 In another study involving 261 injured patients from
Australia, New Zealand, and France (some of whom were included
in the GeoSentinel analysis), the countries from which travelers
had most frequently reported injuries included Morocco, Tunisia,
and Algeria, Thailand, India, Vietnam, and Indonesia. The vast* Corresponding author. Tel.: +33 0 4 91 96 35 35/36; fax: +33 0 4 91 96 89 38.
E-mail address: philippe.brouqui@univmed.fr (P. Brouqui).
1201-9712/$36.00 – see front matter  2009 Published by Elsevier Ltd on behalf of In
doi:10.1016/j.ijid.2009.05.009majority of patients who had traveled to North Africa were seen in
Marseille, while most of the patients who had traveled to
Southeast Asia were seen in Melbourne and Auckland.7 Finally
in an Israeli study conducted in 815 injured travelers, most of the
individuals had been exposed in Asian countries.8
In Marseille, the travel health center and the rabies treatment
center are handled by the same medical team who gather the data
of both units. This double ‘observation’ raised the concern that
travelers seen before traveling, who received pre-travel informa-
tion about rabies risk in their country of destination, had very
different characteristics to those actually injured abroad and
seeking rabies post-exposure prophylaxis.
In this study, we investigated the epidemiology of animal-
associated injuries in a large cohort of travelers from Marseille,
southern France over the last 14 years, and focused on the traveled
country and the animal species involved.
2. Materials and methods
Data were prospectively collected on patients presenting to the
rabies treatment center in Marseille from January 1994 toternational Society for Infectious Diseases.
Figure 1. Numbers of animal-associated injuries in travelers over time (bars) and
proportion of travelers over total injured patients (curve).
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acquired a human or animal-related injury/contact outside of
France, and who were seeking care for rabies post-exposure
prophylaxis (PEP). All injury cases were recorded on standardized
reports that include patient demographic information, place of
exposure, and animal characteristics. Rabies PEP characteristics
have been described elsewhere.7 Datawere captured anonymously
in a Microsoft Access database and transferred to EpiInfo 6.0
software (Centers for Diseases Control and Prevention, Atlanta,
USA) for analysis. Differences in proportionswere given by the Chi-
square test. A p-value of 0.05 was considered signiﬁcant. All p-
values were determined by two-tailed t-test.
3. Results
From 1994 to 2007, a total of 424 injured travelers attended the
rabies treatment center in Marseille, representing 8.2% of all
injured patients attending the center. As shown in Figure 1, the
number of injured travelers increased from 24 per year (range 18–Figure 2. Animal species in injured travelers according to travel destin32) in 1994–2003 to 46 per year (range 36–55) in 2004–2007
(p < 105). The proportion of travelers over total injured patients
increased from 4% in 1994 to 19% in 2007 (p < 106). The number
of cases increased signiﬁcantly by four times in July/August/
September compared to other quarters (p < 106).
As shown in Figure 2, the majority of injured patients seeking
care for rabies PEP were reported from North Africa (41.5%) and
Asia (22.2%). The top ﬁve countries were Algeria (67 patients,
15.8%), Morocco (59 patients, 13.9%), Tunisia (50 patients, 11.8%),
Thailand (46 patients, 10.8%), and Turkey (19 patients, 4.5%). The
ratio ofmales to females was 1.04 and themean agewas 34.5 years
(median age 33 years, range 2–84 years). Patients aged < 15 years
represented 23% of the cohort. The male/female ratio, age, and
traveled countries did not vary signiﬁcantly over time (data not
shown).
Domestic animals accounted for injuries in 308 patients
(72.6%), wild animal in 109 patients (25.7%), and the species of
animal was unidentiﬁed for six patients (1.4%). One case consisted
of a human bite (0.3%). The most common species were dogs
(52.6%) and non-human primates (19.6%). Non-human primate-
related injuries resulted mainly from bites and rarely from
scratches. Cases for which the species was identiﬁed involved
Sangeh macaques in Indonesia and Thailand, baboons and green
monkeys in Kenya, lemurs in Madagascar, Barbary macaques in
North Africa, and capuchin monkeys in Brazil. Cats were involved
in 17.7% of the injury cases, rodents in 3.3%, and bats in 2.4%
(Figure 2).
The probability of injured travelers being attacked by each
animal species varied signiﬁcantly according to the destination
country (Table 1). Travelers injured in Algeria had more than twice
the odds of being attacked by a dog compared to the other parts of
the world, while those returning from Tunisia and the Middle East
had more than eight times and three times the odds of suffering
from a cat attack, respectively. Travelers injured in sub-Saharan
Africa, Madagascar, and Asia were four to six times more likely to
attacked by non-human primates compared to travelers returning
from elsewhere.
Animals were not available for observation by a veterinarian or
for testing in 91.5% of the injury cases. Among 36 injury cases for
which the animal was available, 16 (44.4%) were associated with aation. Eight cases were also reported from North America/Canada.
Table 1
Odds ratios (region/country of travel vs. all other regions) for each animal species
Dog Cat Non-human primate
OR1 (95% CI2) OR (95% CI) OR (95% CI)
North Africa 1.34 (0.89–2.02) 4.78 (2.66–8.66)a 0.09 (0.04–0.22)a
Algeria 2.23 (1.23–4.05)a 0.90 (0.42–1.91) 0.16 (0.04–0.56)a
Morocco 1.37 (0.75–2.51) 1.73 (0.85–3.48) 0.26 (0.08–0.79)a
Tunisia 0.51 (0.26–0.98)a 8.85 (4.45–17.71)a 0.00 (0.00–0.35)a
Sub-Saharan Africa 0.40 (0.18–0.87)a 0.25 (0.04–1.09)a 4.69 (2.20–10.03)a
Madagascar 0.78 (0.25–2.45) 0.00 (0.00–1.58)a 5.09 (1.60–16.33)a
Latin America 0.90 (0.38–2.13) 0.59 (0.14–2.17) 0.98 (0.31–2.88)
Asia 0.66 (0.41–1.09) 0.12 (0.03–0.40)a 6.11 (3.49–10.74)a
Middle East 0.82 (0.32–2.05) 3.26 (1.23–8.52)a 0.18 (0.01–1.28)
OR, odds ratio; CI, conﬁdence interval.
a p < 0.05.
Table 2
Characteristics of cases injured by animals related to a contact with a laboratory
conﬁrmed rabid exposure source or a clinically diagnosed rabid exposure from1994
to 2007
Date of
exposure
Number of
PEP cases
Rabid source Rabies diagnosis Place of
exposure
Nov 1994 1 Species unrecorded Laboratory Ivory Coast
Jul 1995 1 Dog Laboratory Morocco
Oct 1995 1 Dog Laboratory Burkina Faso
Dec 1995 1 Cat Laboratory Morocco
May 1996 1 Dog Laboratory Algeria
Jul 1996 1 Cat Clinical Morocco
Aug 1997 1 Human Clinical Algeria
Aug 1997 1 Dog Laboratory Morocco
Feb 1998 1 Dog Laboratory Tunisia
Aug 1999 1 Dog Laboratory Morocco
Jul 2000 2 Dog Laboratory Morocco
Aug 2000 2 Dog Clinical Mali
May 2002 1 Cat Laboratory Tunisia
Aug 2004 1 Bovid Clinical Morocco
PEP, post-exposure prophylaxis.
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countries endemic for rabies (Table 2).
Only one death was recorded over the 14-year duration of the
survey, occurring in June 1996. A 71-year-old French male
immigrant who was born in Algeria was bitten by his own dog
40 days prior to presentation when he traveled to Algeria to visit
friends and relatives. During his return trip by boat to France, he
exhibited a psychological disorder and hydrophobia and was
admitted to a hospital in Marseille. Despite rabies PEP that was
administered on arrival in Marseille, including vaccine and human
rabies immunoglobulin, he died two days later. Rabies antigenwas
found in brain and skin biopsies. Rabies PEP was provided to 35
close contacts in Marseille. An Algerian woman bitten by the same
dog died from rabies in Algeria at the same time.9
4. Discussion
North-African countries account for 41.5% of the sites where
rabies exposure occurred in the context of travel, and were caused
by domestic dogs and cats. This reinforces the need to provide
persuasive and effective information about rabies risk when
traveling to these parts of the world. Rabies is a public health
problem in North Africa where numerous human cases are
associated with rabid dogs. According to the World Health
Organization (WHO) RabNet database (http://www.who.int/glo-
balatlas/default.asp) and other sources,10 23 human cases were
notiﬁed inMorocco in 2002, 24 in Algeria, and two in Tunisia. Rabid
animal cases were as follows: 343 in Morocco and 102 in Tunisia
(2007), and 900 in Algeria (2004). However, the data collected onrabies incidence are limited and do not represent the reality of this
infection in the ﬁeld.11
In Tunisia, mass campaigns of vaccination have been conducted
in canine populations together with elimination of free-roaming
dogs with some effect; however canine rabies is still prevalent in
Algeria and Morocco due to rapid dog population turnover.10,11
Marseille is a high volume international seaport in southern France
with intensive daily maritime trafﬁc from North African countries.
Most immigrants originating from North Africa who currently live
in theMarseille area travel yearly to Algeria, Morocco, or Tunisia to
visit friends and relatives. Furthermore, Morocco and Tunisia
represent two popular destinations for French tourists.12 Gen-
erally, only a few travelers to North Africa seek pre-travel advice at
our clinic (less than 0.5% of the travelers attending our clinic),
which is not surprising as no speciﬁc vaccination and no malaria
prophylaxis is required to travel to North Africa. Therefore, a
signiﬁcant proportion of travelers exposed to potentially rabid
animals abroad did not seek pre-travel advice from travel clinics,
thus missing the opportunity of being informed of such a risk and
the preventive measures that can be taken. Unfortunately, in the
present study, the proportion of injured travelers who had a pre-
travel consultation was not available.
We suggest that rabies pre-exposure vaccination should be
offered to individuals traveling regularly to North Africa to visit
their relatives and who are at high risk of being exposed to
potentially rabid animal attacks. We have shown that only 6.8% of
travelers experiencing an injurious contact with animals were
vaccinated before traveling to rabies endemic countries.7
On the other hand, increased international travel and tourism to
Asian countries increases the risk of potentially rabid animal-
related injuries. Such travelers are more likely to consult a
specialized travel clinic (14.7% of the travelers attending our
clinic), although most travelers to Thailand and Vietnam seek
medical advice from their general practitioner when their trip does
not include malaria endemic zones.
Together with the elimination of rabies in terrestrial animals
in France in 2001,13 the increasing number of individuals injured
during travel in countries endemic for rabies has changed the
proﬁle of the patients presenting to the rabies treatment center
in Marseille. In order to reduce the incidence of animal-
associated injuries, travelers should be adequately counseled
about animal-associated injuries and rabies risk when visiting
rabies-infected countries, and preventive vaccination should be
proposed when the risk is considered high and when rabies
immune globulin is not available on site. However, the
availability of rabies immune globulin is uncertain in many
cases or data on its availability is out of date.14 To assess the risk
of rabies for travelers, it is essential to examine available
information on human disease occurrence, animal bite incidence,
and prevalence of the disease in the main animal reservoirs.15
This information can be obtained from theWHO RabNet database
but requires a coordinated review of the available data. Pre-
travel advice when addressing rabies prevention should consider
the speciﬁcity of the epidemiology of animal-related injuries in
the traveled country, as well as the traveler’s characteristics.
Travelers should be advised about which species of animal are
potentially aggressive in their destination country so that they
can more easily avoid risk-contacts. Providing comprehensive
information about rabies risk during the pre-travel encounter in
a series of 300 travelers at our clinic resulted in no injurious
contact with animals during their trips, while 3.8% declared that
they had been attacked by animals and a majority mentioned
animal encounters.16
More concentrated efforts from health professionals should be
made in the future to provide information about rabies risk when
traveling to North Africa. This could be achieved by mailing such
P. Gautret et al. / International Journal of Infectious Diseases 14 (2010) e243–e246e246information to general practitioners and travel agencies and by
speciﬁc interventions in selected media.
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